IBB241115C135000
- 13.66
- 0.000.00%
iShares Biotechnology ETF Newsroom
Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop
Amgen Analyst Ratings
Illumina Coverage Resumed at Equal Weight by Morgan Stanley
Amgen Slips as Cantor Cites Safety Concerns Linked to Obesity Candidate
Cantor Fitzgerald Maintains Overweight Rating On Amgen With $405 Price Target, Projecting $33.2B Revenue In 2024; Highlights Pipeline Risks And -4% BMD Loss In AMG-133 Phase 1 Trial
ARKK's Holdings Ranked by SA Quant Grades
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Chevron, Super Micro Computer Top List of Most Shorted Large-cap Stocks in October, Hazeltree Says
10 Health Care Stocks Whale Activity In Today's Session
Alnylam Downgraded at Wolfe on Doubts Over Amvuttra Growth
Tuesday Market Finally Slows Down, Takes a Post Veterans Day Breather | Live Stock
Argenx Upgraded at Wolfe on Myasthenia Gravis Dominance
This Airbnb Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
Argenx Analyst Ratings
Alnylam Pharmaceuticals Analyst Ratings
Market Opens to Fresh Highs | Live Stock
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday As Investors Await Fresh Inflation Report
Baird Maintains Neutral on Mettler-Toledo Intl, Lowers Price Target to $1310
Mettler-Toledo Intl Analyst Ratings
Illumina Analyst Ratings